Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Conmed (CNMD) Gross Margin (2016 - 2025)

Conmed's Gross Margin history spans 16 years, with the latest figure at 58.49% for Q4 2025.

  • For Q4 2025, Gross Margin rose 116.0% year-over-year to 58.49%; the TTM value through Dec 2025 reached 54.59%, down 149.0%, while the annual FY2025 figure was 54.59%, 149.0% down from the prior year.
  • Gross Margin reached 58.49% in Q4 2025 per CNMD's latest filing, up from 49.16% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 58.49% in Q4 2025 to a low of 49.16% in Q3 2025.
  • Average Gross Margin over 5 years is 55.13%, with a median of 55.26% recorded in 2021.
  • Peak YoY movement for Gross Margin: soared 984bps in 2021, then plummeted -736bps in 2025.
  • A 5-year view of Gross Margin shows it stood at 56.89% in 2021, then fell by -8bps to 52.56% in 2022, then grew by 6bps to 55.7% in 2023, then increased by 3bps to 57.33% in 2024, then rose by 2bps to 58.49% in 2025.
  • Per Business Quant, the three most recent readings for CNMD's Gross Margin are 58.49% (Q4 2025), 49.16% (Q3 2025), and 55.01% (Q2 2025).